Intellia Therapeutics
Joseph Snopek, CPA, currently serves as Senior Manager of Financial Reporting and Technical Accounting at Intellia Therapeutics, Inc., a position held since April 2021, after previously holding the role of Manager in the same department. Prior to joining Intellia Therapeutics, Joseph worked at RSM US LLP as a Supervisor in Consulting from November 2020 to April 2021, and at Deloitte as an Audit & Assurance Senior from October 2017 to October 2020. Joseph holds both a Bachelor of Business Administration and a Master of Science in Accounting from the Isenberg School of Management at UMass Amherst.
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.